| Report ID |
2761 |
| Drug Identification Number |
02212358 |
| Brand name |
ZANTAC |
| Common or Proper name |
Ranitidine tablets |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
RANITIDINE |
| Strength(s) |
300MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL |
| Packaging size |
60's |
| ATC code |
A02BA |
| ATC description |
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage |
Disruption of the manufacture of the drug. |
| Anticipated start date |
|
| Actual start date |
2017-04-19 |
| Estimated end date |
|
| Actual end date |
2017-09-14 |
| Shortage status |
Resolved |
| Updated date |
2020-02-27 |
| Company comments |
This product has been discontinued. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
